Prevalence and Risk Factors of Comorbid Obesity in Chinese Patients with Bipolar Disorder

References

• Grande I, Berk M, Birmaher B, et al. Bipolar disorder. Lancet. 2016;387(10027):1561–1572. doi:10.1016/S0140-6736(15)00241-X
   PubMed Web of Science ®Google Scholar
• Vieta E, Salagre E, Grande I, et al. Early intervention in bipolar disorder. Am J Psychiatry. 2018;175(5):411–426. doi:10.1176/appi.ajp.2017.17090972
   PubMed Web of Science ®Google Scholar
• Bessonova L, Ogden K, Doane MJ, et al. The economic burden of bipolar disorder in the United States: a systematic literature review. ClinicoEconomics Outcomes Res. 2020;12:481–497. doi:10.2147/CEOR.S259338
   PubMed Web of Science ®Google Scholar
• Chan JKN, Wong CSM, Yung NCL, et al. Excess mortality and life-years lost in people with bipolar disorder: an 11-year population-based cohort study. Epidemiol Psychiatr Sci. 2021;30:e39. doi:10.1017/S2045796021000305
   PubMed Web of Science ®Google Scholar
• McElroy SL. Obesity in patients with severe mental illness: overview and management. J Clin Psychiatry. 2009;70(Suppl 3):12–21. doi:10.4088/JCP.7075su1c.03
   PubMedGoogle Scholar
• Keck PE, McElroy SL. Bipolar disorder, obesity, and pharmacotherapy-associated weight gain. J Clin Psychiatry. 2003;64(12):1426–1435. doi:10.4088/JCP.v64n1205
   PubMed Web of Science ®Google Scholar
• Sicras A, Rejas J, Navarro R, et al. Metabolic syndrome in bipolar disorder: a cross-sectional assessment of a Health Management Organization database. Bipolar Disord. 2008;10(5):607–616. doi:10.1111/j.1399-5618.2008.00599.x
   PubMed Web of Science ®Google Scholar
• Weber NS, Fisher JA, Cowan DN, et al. Psychiatric and general medical conditions comorbid with bipolar disorder in the national hospital discharge survey. Psychiatr Serv. 2011;62(10):1152–1158. doi:10.1176/ps.62.10.pss6210_1152
   PubMed Web of Science ®Google Scholar
• Kim B, Kim SJ, Son JI, et al. Weight change in the acute treatment of bipolar I disorder: a naturalistic observational study of psychiatric inpatients. J Affect Disord. 2008;105(1–3):45–52. doi:10.1016/j.jad.2007.04.006
   PubMed Web of Science ®Google Scholar
• Menculini G, Verdolini N, Brufani F, et al. Comorbidities, depression severity, and circadian rhythms disturbances as clinical correlates of duration of untreated illness in affective disorders. Medicina. 2021;57:5.
   Google Scholar
• Maina G, Salvi V, Vitalucci A, et al. Prevalence and correlates of overweight in drug-naïve patients with bipolar disorder. J Affect Disord. 2008;110(1–2):149–155. doi:10.1016/j.jad.2007.12.233
   PubMed Web of Science ®Google Scholar
• Cole DP, Thase ME, Mallinger AG, et al. Slower treatment response in bipolar depression predicted by lower pretreatment thyroid function. Am J Psychiatry. 2002;159(1):116–121. doi:10.1176/appi.ajp.159.1.116
   PubMed Web of Science ®Google Scholar
• Bahrami S, Steen NE, Shadrin A, et al. Shared genetic loci between body mass index and major psychiatric disorders: a genome-wide association study. JAMA Psychiatry. 2020;77(5):503–512. doi:10.1001/jamapsychiatry.2019.4188
   PubMed Web of Science ®Google Scholar
• González-Muniesa P, Mártinez-González MA, Hu FB, et al. Obesity. Nat Rev Dis Primers. 2017;3:17034. doi:10.1038/nrdp.2017.34
   PubMed Web of Science ®Google Scholar
• Deng T, Lyon CJ, Bergin S, et al. Obesity, Inflammation, and Cancer. Annu Rev Pathol. 2016;11:421–449. doi:10.1146/annurev-pathol-012615-044359
   PubMed Web of Science ®Google Scholar
• Scherer PE, Hill JA. Obesity, diabetes, and cardiovascular diseases: a compendium. Circ Res. 2016;118(11):1703–1705. doi:10.1161/CIRCRESAHA.116.308999
   PubMed Web of Science ®Google Scholar
• Di Angelantonio E, Bhupathiraju SN, Gao P, et al. Body-mass index and all-cause mortality: individual-participant-data meta-analysis of 239 prospective studies in four continents. Lancet. 2016;388(10046):776–786. doi:10.1016/S0140-6736(16)30175-1
   PubMed Web of Science ®Google Scholar
• Preston SH, Vierboom YC, Stokes A. The role of obesity in exceptionally slow US mortality improvement. Proc Natl Acad Sci USA. 2018;115(5):957–961. doi:10.1073/pnas.1716802115
   PubMed Web of Science ®Google Scholar
• Rubin R. Profile: institute for health metrics and evaluation, WA, USA. Lancet. 2017;389(10068):493. doi:10.1016/S0140-6736(17)30263-5
   PubMed Web of Science ®Google Scholar
• Pan XF, Wang L, Pan A. Epidemiology and determinants of obesity in China. Lancet Diabetes Endocrinol. 2021;9(6):373–392. doi:10.1016/S2213-8587(21)00045-0
   PubMed Web of Science ®Google Scholar
• Boutari C, Mantzoros CS. A 2022 update on the epidemiology of obesity and a call to action: as its twin COVID-19 pandemic appears to be receding, the obesity and dysmetabolism pandemic continues to rage on. Metabolism. 2022;133:155217. doi:10.1016/j.metabol.2022.155217
   PubMedGoogle Scholar
• Fagiolini A, Kupfer DJ, Rucci P, et al. Suicide attempts and ideation in patients with bipolar I disorder. J Clin Psychiatry. 2004;65(4):509–514. doi:10.4088/JCP.v65n0409
   PubMed Web of Science ®Google Scholar
• Fagiolini A, Kupfer DJ, Houck PR, et al. Obesity as a correlate of outcome in patients with bipolar I disorder. Am J Psychiatry. 2003;160(1):112–117. doi:10.1176/appi.ajp.160.1.112
   PubMed Web of Science ®Google Scholar
• Yi W, Wu H, Li R, et al. Prevalence and associated factors of obesity and overweight in Chinese patients with bipolar disorder. Front Psychiatry. 2022;13:984829. doi:10.3389/fpsyt.2022.984829
   PubMed Web of Science ®Google Scholar
• Chen W. Guidelines for medical nutrition treatment of overweight/obesity in China (2021). Asia Pac J Clin Nutr. 2022;31(3):450–482.
   PubMed Web of Science ®Google Scholar
• Onat A, Altay S, Karadeniz Y. Clinical significance and potential mechanism of discordance between apolipoprotein B and LDL-cholesterol. J Am Coll Cardiol. 2016;67(25):3023–3024. doi:10.1016/j.jacc.2016.02.083
   PubMed Web of Science ®Google Scholar
• Rajput-Williams J, Knott TJ, Wallis SC, et al. Variation of apolipoprotein-B gene is associated with obesity, high blood cholesterol levels, and increased risk of coronary heart disease. Lancet. 1988;2(8626–8627):1442–1446. doi:10.1016/S0140-6736(88)90930-0
   PubMed Web of Science ®Google Scholar
• Law A, Wallis SC, Powell LM, et al. Common DNA polymorphism within coding sequence of apolipoprotein B gene associated with altered lipid levels. Lancet. 1986;1(8493):1301–1303. doi:10.1016/S0140-6736(86)91222-5
   PubMed Web of Science ®Google Scholar
• Hassan NE, El-Masry SA, Zarouk WA, et al. Apolipoprotein B polymorphism distribution among a sample of obese Egyptian females with visceral obesity and its influence on lipid profile. J Genet Eng Biotechnol. 2015;13(2):177–183. doi:10.1016/j.jgeb.2015.09.005
   PubMedGoogle Scholar
• Williams K, Sniderman AD, Sattar N, et al. Comparison of the associations of apolipoprotein B and low-density lipoprotein cholesterol with other cardiovascular risk factors in the Insulin Resistance Atherosclerosis Study (IRAS). Circulation. 2003;108(19):2312–2316. doi:10.1161/01.CIR.0000097113.11419.9E
   PubMed Web of Science ®Google Scholar
• Kimura Y, Tsukui D, Kono H. Uric acid in inflammation and the pathogenesis of atherosclerosis. Int J Mol Sci. 2021;22:22. doi:10.3390/ijms222212394
   Web of Science ®Google Scholar
• Kanellis J, Watanabe S, Li JH, et al. Uric acid stimulates monocyte chemoattractant protein-1 production in vascular smooth muscle cells via mitogen-activated protein kinase and cyclooxygenase-2. Hypertension. 2003;41(6):1287–1293. doi:10.1161/01.HYP.0000072820.07472.3B
   PubMed Web of Science ®Google Scholar
• Tamba S, Nishizawa H, Funahashi T, et al. Relationship between the serum uric acid level, visceral fat accumulation and serum adiponectin concentration in Japanese men. Intern Med. 2008;47(13):1175–1180. doi:10.2169/internalmedicine.47.0603
   PubMed Web of Science ®Google Scholar
• Borghi C, Rosei EA, Bardin T, et al. Serum uric acid and the risk of cardiovascular and renal disease. J Hypertens. 2015;33(9):1729–1741; discussion 1741. doi:10.1097/HJH.0000000000000701
   PubMed Web of Science ®Google Scholar
• Kuwabara M, Hisatome I, Niwa K, et al. Uric acid is a strong risk marker for developing hypertension from prehypertension: a 5-year Japanese cohort study. Hypertension. 2018;71(1):78–86. doi:10.1161/HYPERTENSIONAHA.117.10370
   PubMed Web of Science ®Google Scholar
• Cheang C, Law S, Ren J, et al. Prevalence of hyperuricemia in patients with severe obesity and the relationship between serum uric acid and severe obesity: a decade retrospective cross-section study in Chinese adults. Front Public Health. 2022;10:986954. doi:10.3389/fpubh.2022.986954
   PubMed Web of Science ®Google Scholar
• Vander Schaft N, Brahimaj A, Wen KX, et al. The association between serum uric acid and the incidence of prediabetes and type 2 diabetes mellitus: the Rotterdam study. PLoS One. 2017;12(6):e0179482. doi:10.1371/journal.pone.0179482
   PubMed Web of Science ®Google Scholar
• Dai X, Yuan J, Yao P, et al. Association between serum uric acid and the metabolic syndrome among a middle- and old-age Chinese population. Eur J Epidemiol. 2013;28(8):669–676. doi:10.1007/s10654-013-9829-4
   PubMed Web of Science ®Google Scholar
• Albert U, De Cori D, Aguglia A, et al. Increased uric acid levels in bipolar disorder subjects during different phases of illness. J Affect Disord. 2015;173:170–175. doi:10.1016/j.jad.2014.11.005
   PubMed Web of Science ®Google Scholar
• Chen J, Chen H, Feng J, et al. Association between hyperuricemia and metabolic syndrome in patients suffering from bipolar disorder. BMC Psychiatry. 2018;18(1):390. doi:10.1186/s12888-018-1952-z
   PubMedGoogle Scholar
• Lee NY, Kim SH, Cho B, et al. Patients taking medications for bipolar disorder are more prone to metabolic syndrome than Korea’s general population. Prog Neuropsychopharmacol Biol Psychiatry. 2010;34(7):1243–1249. doi:10.1016/j.pnpbp.2010.06.029
   PubMed Web of Science ®Google Scholar
• Clemente-Postigo M, Queipo-Ortuño MI, Fernandez-Garcia D, et al. Adipose tissue gene expression of factors related to lipid processing in obesity. PLoS One. 2011;6(9):e24783. doi:10.1371/journal.pone.0024783
   PubMed Web of Science ®Google Scholar
• Klop B, Wouter Jukema J, Rabelink TJ, et al. A physician’s guide for the management of hypertriglyceridemia: the etiology of hypertriglyceridemia determines treatment strategy. Panminerva Med. 2012;54(2):91–103.
   PubMed Web of Science ®Google Scholar
• Zou Y, Sheng G, Yu M, et al. The association between triglycerides and ectopic fat obesity: an inverted U-shaped curve. PLoS One. 2020;15(11):e0243068. doi:10.1371/journal.pone.0243068
   PubMed Web of Science ®Google Scholar
• Slabber M, Barnard HC, Kuyl JM, et al. Effects of a low-insulin-response, energy-restricted diet on weight loss and plasma insulin concentrations in hyperinsulinemic obese females. Am J Clin Nutr. 1994;60(1):48–53. doi:10.1093/ajcn/60.1.48
   PubMed Web of Science ®Google Scholar
• Ludwig DS. The glycemic index: physiological mechanisms relating to obesity, diabetes, and cardiovascular disease. JAMA. 2002;287(18):2414–2423. doi:10.1001/jama.287.18.2414
   PubMed Web of Science ®Google Scholar
• Lin HV, Accili D. Hormonal regulation of hepatic glucose production in health and disease. Cell Metab. 2011;14(1):9–19. doi:10.1016/j.cmet.2011.06.003
   PubMed Web of Science ®Google Scholar
• Petersen MC, Vatner DF, Shulman GI. Regulation of hepatic glucose metabolism in health and disease. Nat Rev Endocrinol. 2017;13(10):572–587. doi:10.1038/nrendo.2017.80
   PubMed Web of Science ®Google Scholar
• Lucan SC, DiNicolantonio JJ. How calorie-focused thinking about obesity and related diseases may mislead and harm public health. An alternative. Public Health Nutr. 2015;18(4):571–581. doi:10.1017/S1368980014002559
   PubMed Web of Science ®Google Scholar
• Taubes G. The science of obesity: what do we really know about what makes us fat? An essay by Gary Taubes. BMJ. 2013;346:f1050. doi:10.1136/bmj.f1050
   PubMedGoogle Scholar
• Ludwig DS, Friedman MI. Increasing adiposity: consequence or cause of overeating? JAMA. 2014;311(21):2167–2168. doi:10.1001/jama.2014.4133
   PubMed Web of Science ®Google Scholar
• Chaput JP, Tremblay A, Rimm EB, et al. A novel interaction between dietary composition and insulin secretion: effects on weight gain in the Quebec family study. Am J Clin Nutr. 2008;87(2):303–309. doi:10.1093/ajcn/87.2.303
   PubMed Web of Science ®Google Scholar
• Ebbeling CB, Leidig MM, Feldman HA, et al. Effects of a low-glycemic load vs low-fat diet in obese young adults: a randomized trial. JAMA. 2007;297(19):2092–2102. doi:10.1001/jama.297.19.2092
   PubMed Web of Science ®Google Scholar
• Wang Y, Spolitu S, Zadroga JA, et al. Hepatocyte Rap1a contributes to obesity- and statin-associated hyperglycemia. Cell Rep. 2022;40(8):111259. doi:10.1016/j.celrep.2022.111259
   PubMed Web of Science ®Google Scholar
• van Winkel R, De Hert M, Van Eyck D, et al. Prevalence of diabetes and the metabolic syndrome in a sample of patients with bipolar disorder. Bipolar Disord. 2008;10(2):342–348. doi:10.1111/j.1399-5618.2007.00520.x
   PubMed Web of Science ®Google Scholar
• Regenold WT, Thapar RK, Marano C, et al. Increased prevalence of type 2 diabetes mellitus among psychiatric inpatients with bipolar I affective and schizoaffective disorders independent of psychotropic drug use. J Affect Disord. 2002;70(1):19–26. doi:10.1016/S0165-0327(01)00456-6
   PubMed Web of Science ®Google Scholar
• Cassidy F, Ahearn E, Carroll BJ. Elevated frequency of diabetes mellitus in hospitalized manic-depressive patients. Am J Psychiatry. 1999;156(9):1417–1420. doi:10.1176/ajp.156.9.1417
   PubMed Web of Science ®Google Scholar
• Yoo JJ, Cho EJ, Chung GE, et al. Nonalcoholic fatty liver disease is a precursor of new-onset metabolic syndrome in metabolically healthy young adults. J Clin Med. 2022;11:4. doi:10.3390/jcm11040935
   Web of Science ®Google Scholar
• Lorenzo C, Hanley AJ, Rewers MJ, et al. The association of alanine aminotransferase within the normal and mildly elevated range with lipoproteins and apolipoproteins: the insulin resistance atherosclerosis study. Diabetologia. 2013;56(4):746–757. doi:10.1007/s00125-012-2826-4
   PubMed Web of Science ®Google Scholar
• Laine S, Sjöros T, Vähä-Ypyä H, et al. Body adiposity, but not elements of objectively measured sedentary behavior or physical activity, is associated with circulating liver enzymes in adults with overweight and obesity. Front Endocrinol. 2021;12:655756. doi:10.3389/fendo.2021.655756
   PubMed Web of Science ®Google Scholar
• Fraser A, Longnecker MP, Lawlor DA. Prevalence of elevated alanine aminotransferase among US adolescents and associated factors: NHANES 1999–2004. Gastroenterology. 2007;133(6):1814–1820. doi:10.1053/j.gastro.2007.08.077
   PubMed Web of Science ®Google Scholar
• Tsai SY, Lee CH, Kuo CJ, et al. A retrospective analysis of risk and protective factors for natural death in bipolar disorder. J Clin Psychiatry. 2005;66(12):1586–1591. doi:10.4088/JCP.v66n1215
   PubMed Web of Science ®Google Scholar